Life Science Tools Market by Technology (Cell Biology Technology, Genomic Technology, Proteomics Technology), Product (Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry), Offerings, Lab Ownership, Lab Size, End-User - Global Forecast 2024-2030
The Life Science Tools Market size was estimated at USD 203.93 billion in 2023 and expected to reach USD 226.14 billion in 2024, at a CAGR 11.21% to reach USD 429.19 billion by 2030.
Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.
Regional Insights
The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Life Science Tools Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Growing need for efficient tools for early diagnosis of chronic diseases
- Surge in investments toward biotech R&D activities from government and non-government organizations
- Applications of genomic and proteomic technologies for precision medicine
- Market Restraints
- High cost of life science tools
- Market Opportunities
- Robust technological advancements in life science tools
- Rapid progress and development of life-science tools in the single-cell isolation and analysis
- Market Challenges
- Quality control issues associated with life science tools
- Market Segmentation Analysis
- Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
- End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Life Science Tools Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- Bruker advances NMR magnet portfolio, innovates in industrial solutions
Bringing innovation and high-quality technology to the life science tools market, Bruker continues to advance their NMR magnet portfolio. With a commitment to industrial solutions, Bruker maintains the highest standards for their NMR magnets, ensuring that they deliver accurate and reliable results for various applications. Bruker remains dedicated to researching and developing cutting-edge technologies to drive progress in research or commercial settings. Bruker's NMR magnets remain a critical tool for unlocking new insights and driving progress in the life science industry.
BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
Bio-Techne has recently completed its investment in Wilson Wolf Manufacturing, a company that provides custom manufacturing solutions to the life science tools industry. With this investment, Bio-Techne is now strategically positioned to expand its portfolio of life science tools offerings by offering custom manufacturing solutions to its customers. This can allow Bio-Techne to better serve its growing customer base and continue to drive innovation in the life science tools market. The investment also aligns with Bio-Techne's commitment to providing high-quality solutions that enable researchers to make breakthrough discoveries in life science. With Wilson Wolf Manufacturing as a strategic partner, Bio-Techne is poised to continue its growth trajectory and provide unparalleled customer service and support.
UK boosts life science innovation with £277 million funding
The UK government recently announced an investment of approximately USD 299 million to boost innovation in the life science sector. The funding is allocated to various initiatives, including efforts to develop new diagnostic tools, vaccines, and therapies for diseases such as cancer, diabetes, and dementia. This investment represents a significant step towards the UK's goal of becoming a world-leading center for life sciences innovation. With resources devoted to research and development, UK scientists and researchers can have the support they need to make groundbreaking discoveries in life sciences.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Life Science Tools Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnóstica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.
Market Segmentation & Coverage
This research report categorizes the Life Science Tools Market to forecast the revenues and analyze trends in each of the following sub-markets:- Technology
- Cell Biology Technology
- Genomic Technology
- Proteomics Technology
- Product
- Cell Culture Systems & 3D Cell Culture
- Media
- Reagents
- Sera
- Cloning & Genome Engineering
- Flow Cytometry
- Liquid Chromatography
- Mass Spectrometry
- Microscopy & Electron Microscopy
- Next Generation Sequencing
- Nuclear Magnetic Resonance
- Nucleic Acid Microarray
- Nucleic Acid Preparation
- PCR & qPCR
- Sanger Sequencing
- Transfection Devices & Gene Delivery Technologies
- Offerings
- Consumables
- Instrument
- Services
- Lab Ownership
- Private
- Public
- Lab Size
- Large
- Medium
- Small
- End-User
- Academic Research Institutes
- Biotechnology Companies
- Contract Research Organization/ Contract Manufacturing Organization
- Diagnostic Laboratories
- Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Cell Culture Systems & 3D Cell Culture
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing need for efficient tools for early diagnosis of chronic diseases
- 5.1.1.2. Surge in investments toward biotech R&D activities from government and non-government organizations
- 5.1.1.3. Applications of genomic and proteomic technologies for precision medicine
- 5.1.2. Restraints
- 5.1.2.1. High cost of life science tools
- 5.1.3. Opportunities
- 5.1.3.1. Robust technological advancements in life science tools
- 5.1.3.2. Rapid progress and development of life-science tools in the single-cell isolation and analysis
- 5.1.4. Challenges
- 5.1.4.1. Quality control issues associated with life science tools
- 5.2. Market Segmentation Analysis
- 5.2.1. Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
- 5.2.2. End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
- 5.3. Market Trend Analysis
- 5.3.1. Increase in life science research activities and ongoing advancements in life science tools in the Americas
- 5.3.2. Growing focus on medical research to alleviate the burden of diseases in the APAC region
- 5.3.3. Government investments and initiatives for the advancement of the healthcare sector in the EMEA region
- 5.4. Cumulative Impact of Russia-Ukraine Conflict
- 5.5. Cumulative Impact of High Inflation
- 5.6. Porter’s Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
- 5.7. Value Chain & Critical Path Analysis
- 5.8. Regulatory Framework Analysis
- 5.9. Client Customization
- 6. Life Science Tools Market, by Technology
- 6.1. Introduction
- 6.2. Cell Biology Technology
- 6.3. Genomic Technology
- 6.4. Proteomics Technology
- 7. Life Science Tools Market, by Product
- 7.1. Introduction
- 7.2. Cell Culture Systems & 3D Cell Culture
- 7.3. Cloning & Genome Engineering
- 7.4. Flow Cytometry
- 7.5. Liquid Chromatography
- 7.6. Mass Spectrometry
- 7.7. Microscopy & Electron Microscopy
- 7.8. Next Generation Sequencing
- 7.9. Nuclear Magnetic Resonance
- 7.10. Nucleic Acid Microarray
- 7.11. Nucleic Acid Preparation
- 7.12. PCR & qPCR
- 7.13. Sanger Sequencing
- 7.14. Transfection Devices & Gene Delivery Technologies
- 8. Life Science Tools Market, by Offerings
- 8.1. Introduction
- 8.2. Consumables
- 8.3. Instrument
- 8.4. Services
- 9. Life Science Tools Market, by Lab Ownership
- 9.1. Introduction
- 9.2. Private
- 9.3. Public
- 10. Life Science Tools Market, by Lab Size
- 10.1. Introduction
- 10.2. Large
- 10.3. Medium
- 10.4. Small
- 11. Life Science Tools Market, by End-User
- 11.1. Introduction
- 11.2. Academic Research Institutes
- 11.3. Biotechnology Companies
- 11.4. Contract Research Organization/ Contract Manufacturing Organization
- 11.5. Diagnostic Laboratories
- 11.6. Hospitals
- 12. Americas Life Science Tools Market
- 12.1. Introduction
- 12.2. Argentina
- 12.3. Brazil
- 12.4. Canada
- 12.5. Mexico
- 12.6. United States
- 13. Asia-Pacific Life Science Tools Market
- 13.1. Introduction
- 13.2. Australia
- 13.3. China
- 13.4. India
- 13.5. Indonesia
- 13.6. Japan
- 13.7. Malaysia
- 13.8. Philippines
- 13.9. Singapore
- 13.10. South Korea
- 13.11. Taiwan
- 13.12. Thailand
- 13.13. Vietnam
- 14. Europe, Middle East & Africa Life Science Tools Market
- 14.1. Introduction
- 14.2. Denmark
- 14.3. Egypt
- 14.4. Finland
- 14.5. France
- 14.6. Germany
- 14.7. Israel
- 14.8. Italy
- 14.9. Netherlands
- 14.10. Nigeria
- 14.11. Norway
- 14.12. Poland
- 14.13. Qatar
- 14.14. Russia
- 14.15. Saudi Arabia
- 14.16. South Africa
- 14.17. Spain
- 14.18. Sweden
- 14.19. Switzerland
- 14.20. Turkey
- 14.21. United Arab Emirates
- 14.22. United Kingdom
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2023
- 15.2. FPNV Positioning Matrix, 2023
- 15.3. Competitive Scenario Analysis
- 15.3.1. Bruker advances NMR magnet portfolio, innovates in industrial solutions
- 15.3.2. BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
- 15.3.3. UK boosts life science innovation with £277 million funding
- 15.3.4. Illumina, GenoScreen launched next-generation sequencing innovation to eliminate TB
- 15.3.5. Berkeley Lights Completed Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
- 15.3.6. Waters Corporation launched the next generation Alliance iS HPLC System
- 15.3.7. Patient Square Capital Partnered with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities
- 15.3.8. GenScript expands footprint in Singapore to provide premium Gene Synthesis service
- 15.3.9. SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo MS system
- 15.3.10. Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado
- 15.3.11. Cytek Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
- 15.3.12. Tecan collaborates with Element Biosciences to provide benchtop NGS
- 15.3.13. Agilent to collaborate with Quest Diagnostics to extend access to the Agilent Resolution ctDx FIRST Liquid Biopsy test
- 15.3.14. Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
- 15.3.15. Novo Holdings invests in a proteomics technology company, Evosep
- 15.3.16. Agilent Acquired Life Sciences Company Avida Biomed
- 15.3.17. QIAGEN and Helix Launched Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
- 15.3.18. Bruker enters into a strategic partnership with Biognosys
- 15.3.19. Charles River Labs expands CGT capabilities into Cheshire
- 15.3.20. Neogen Launches New Genomic Management Technology
- 15.3.21. MedGenome Raises USD 50M To Map The Human Genome
- 15.3.22. Thermo Fisher Launches Next-Generation Sequencing Platform for Labs
- 16. Competitive Portfolio
- 16.1. Key Company Profiles
- 16.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook